Guggenheim Capital LLC Coherus Bio Sciences, Inc. Transaction History

Guggenheim Capital LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$5.86 - $13.23 $31,778 - $71,746	-5,423 Reduced 28.69%	13,480 $98,000
Q1 2022 May 16, 2022	SELL	$10.92 - $16.41 $186,349 - $280,036	-17,065 Reduced 47.44%	18,903 $245,000
Q4 2021 Feb 14, 2022	SELL	$15.81 - $18.99 $829,740 - $996,633	-52,482 Reduced 59.34%	35,968 $574,000
Q3 2021 Nov 15, 2021	BUY	$12.68 - $17.79 $100,133 - $140,487	7,897 Added 9.8%	88,450 $1.42 Million
Q2 2021 Aug 13, 2021	BUY	$12.95 - $15.41 $423,076 - $503,444	32,670 Added 68.23%	80,553 $1.11 Million
Q1 2021 May 13, 2021	SELL	$14.42 - $21.39 $411,287 - $610,085	-28,522 Reduced 37.33%	47,883 $699,000
Q4 2020 Feb 16, 2021	BUY	$16.56 - $18.94 $1.1 Million - $1.26 Million	66,366 Added 661.08%	76,405 $1.33 Million
Q3 2020 Nov 13, 2020	BUY	$17.41 - $19.89 $174,778 - $199,675	10,039 New	10,039 $184,000
Q2 2018 Aug 14, 2018	SELL	$10.25 - $17.45 $161,222 - $274,471	-15,729 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$9.1 - $13.7 $4,722 - $7,110	-519 Reduced 3.19%	15,729 $173,000
Q4 2017 Feb 14, 2018	SELL	$8.35 - $14.4 $6,112 - $10,540	-732 Reduced 4.31%	16,248 $142,000
Q3 2017 Nov 14, 2017	BUY	$11.1 - $14.5 $188,478 - $246,210	16,980	16,980 $227,000

135

77.9M

40.7K

50.1K

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $122M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Guggenheim Capital LLC with notifications on news.